Back to the search results

Klinikum Neumarkt

Klinikum Neumarkt
Klinikum Neumarkt
  • Number of beds: 460
  • Number of specialist departments: 19
  • Number of inpatient cases: 22.817
  • Number of partial inpatient cases: 492
  • Number of outpatient cases: 47.001
  • Hospital owners: Landkreis Neumarkt i.d.OPf. - Kommunale Anstalt des öffentlichen Rechts des Landkreises Neumarkt i.d.OPf.
  • Type of provider: öffentlich
  • Academic teaching hospital
      • Friedrich-Alexander-Universität Erlangen-Nürnberg
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Quantity performed 125
Exception? No exception
Quantity performed 26
Exception? No exception
Quantity performed 259
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 125
Quantity forecast year: 138
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 259
Quantity forecast year: 276
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 26
Quantity forecast year: 21
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ31 Guideline for the care of proximal femur fractures (QSFFx-RL)
CQ07 Measures for quality assurance in the care of pre-term and full-term neonates – perinatal focus
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
147 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
105 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
105 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Schutzkonzept für vulnerable Gruppen im Klinikum Neumarkt
Gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Dokumentation im Mitarbeiterportal, zentrale Server-Laufwerke, Handbücher (z. B. Qualitäts- und Risikomanagement, Risikobericht, Maßnahmenpläne, Standards, Verfahrensanweisungen) sowie in Rückmelde-Systemen (CIRS, Beschwerden, Verbesserungen) - fortlaufende Aktualisierung

09.08.2024

Umgang mit Medikamenten

07.08.2024

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • a) Bestellung und Abgabe (Amondis), b) Herstellung (Lennartz, Zenzy).
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Maßnahmen zur Vermeidung von Fehlern im Dosierintervall
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

FAU Erlangen (Apl. Prof. Dr. H. Scholz, Apl. Prof. Dr. F. Seifert), JMU Würzburg (Apl. Prof. Dr. U. Schwemmer), LMU München (Apl. Prof. Dr. C. Schäfer), RU Bochum (Apl. Prof. Dr. P. Grewe), Uni Rostock (Apl. Prof. Dr. B. M. Rau), Uni Regensburg (Apl. Prof. Dr. P. Grewe)

Explanation

Lehrkrankenhaus der Friedrich-Alexander Universität Erlangen-Nürnberg , Universität Groningen, Universität Utrecht, Evangelische Hochschule Nürnberg - Kooperationspartner Studiengang Pflege (R. Sossau), Uni Witten/Herdecke, Technische Hochschule Nürnberg und Technische Hochschule Regensburg

Explanation

FIRE-4(AIO-KRK-0114), Phase III; Renaissance (FLOT5), Phase III; Onkotrakt (Psychoonkologie), Register; EDIUM, Beobachtungsstudie; PANCALYZE, chirurgische Studie; DigiDem (FAU); AZURITE, Register

Explanation

LMU München (Prof. Dr. C. Schäfer), Universität Rostock (Prof. Dr. B. M. Rau), Universität Regensburg (Prof. Dr. B. M. Rau)

Explanation

Elderly (AIO-KRK-0117), Phase II.

Explanation

Explanation

Perioperative Darmdekontamination bei elektiver colorectaler Chirurgie (Klinikum Neumarkt, Klinikum Agatharied, LMU München - Prof. Dr. B. M. Rau); WIZEN Studie (Co-Investigator Klinikum Neumarkt, Prof. Dr. B. M. Rau)

Explanation

Universität Groningen, Universität Utrecht, Universität Dublin, Hanze Institut Oldenburg, Steinbeis Hochschule Essen, Evangelische Hochschule Nürnberg und Technische Hochschule Nürnberg, Universität Regensburg (Prof. Dr. B. M. Rau),

Training in other healing professions
Comment

Kooperation mit dem CEKIB Nürnberg

Comment

Kooperation mit dem CEKiB Nürnberg

Comment

Neumarkter Akademie für Gesundheitsberufe gGmbH, einjährige Ausbildung zum Pflegefachhelfer (m/w/d)

Comment

Neumarkter Akademie für Gesundheitsberufe gGmbH, dreijährige Ausbildung zum Pflegefachmann (m/w/d)

Comment

Kooperation mit dem CEKIB Nürnberg

Comment

Kooperation mit dem CEKIB Nürnberg

Stefanie Meyer

Patientenfürsprecherin am Klinikum Neumarkt

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-5995
Mail: ed.tkramuen.mukinilk@rehcerpsreufnetneitap

Julia Scherer

Marketing und Kommunikation

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-5390
Mail: ed.tkramuen.mukinilk@tnemeganamedrewhcseb

Julika König

Marketing und Kommunikation

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-3810
Mail: ed.tkramuen.mukinilk@tnemeganamedrewhcseb

Dipl.-Verww. (FH) Xaver Hirschmann

Qualitätsmanagement

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-2300
Mail: ed.tkramuen.mukinilk@nnamhcsrih.revax

Apotheker Wolfgang Dombert

Leitung Apotheke

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-3639
Mail: ed.tkramuen.mukinilk@trebmod.gnagflow

Matthias Varadi

Leitung Technik

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-3822
Mail: ed.tkramuen.mukinilk@idarav.saihttam

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181-420-0
Mail: ed.tkramuen.mukinilk@ofni

René Sossau

Pflegedirektor

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-3713
Mail: ed.tkramuen.mukinilk@noitkeridegelfp

Dipl. Pflegewirt (FH) Markus Graf

Vorstand

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-0
Mail: ed.tkramuen.mukinilk@ofni

Dipl. Pflegewirt (FH), M.A Markus Graf

Vorstand

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-0
Mail: ed.tkramuen.mukinilk@ofni

Dr. med. Ute Meister

Ärztliche Direktorin, Chefärztin der Abteilung Gefäßchirurgie

Nürnberger Straße 12
92318 Neumarkt

Phone: 09181 -420-3716
Mail: ed.tkramuen.mukinilk@eigrurihcsseafeg

IK: 260930301

Location number: 771096000

Brustkrebszentrum

Certified until: 10.2028

Chest Pain Unit

Certified until: 04.2030

Darmkrebszentrum

Certified until: 11.2028

Dysplasie-Einheit

Certified until: 04.2027

EndoProthetikZentrum

Certified until: 10.2026

Gynäkologisches Krebszentrum

Certified until: 10.2028

Minimalinvasive Chirurgie

Certified until: 05.2028

Prostatakrebszentrum

Certified until: 10.2027

Stroke Unit

Certified until: 07.2026

TraumaNetzwerk

Certified until: 08.2027

TraumaZentrum

Certified until: 04.2027